Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,701
Closed -$822K 419
2023
Q2
$822K Buy
+3,701
New +$859K 0.1% 267
2023
Q1
Sell
-4,046
Closed -$1.06M 388
2022
Q4
$1.06M Sell
4,046
-968
-19% -$259K 0.18% 188
2022
Q3
$1.13M Buy
5,014
+1,877
+60% +$455K 0.22% 158
2022
Q2
$763K Buy
3,137
+1,307
+71% +$320K 0.16% 213
2022
Q1
$443K Buy
1,830
+66
+4% +$15.2K 0.16% 225
2021
Q4
$397K Buy
+1,764
New +$372K 0.23% 171

Other funds holding AMGN

CenterBook Partners's AMGN Position: Q3 2023 in Review

CenterBook Partners sold out of Amgen (AMGN) in Q3 2023, closing a stake of 3,701 shares — an estimated $822K sold.

CenterBook Partners first reported a position in AMGN in Q4 2021 and held it in 6 quarters. The position peaked at $1.13M in Q3 2022. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.

  • CenterBook Partners reported no remaining Amgen position as of Q3 2023 after selling out during the quarter.
  • CenterBook Partners sold 3,701 Amgen shares in Q3 2023, an estimated $822K.
  • CenterBook Partners first reported a position in Amgen in Q4 2021 and held it in 6 quarters.
  • CenterBook Partners's Amgen position peaked at $1.13M in Q3 2022.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.

Based on CenterBook Partners's 13F filing for Q3 2023, filed 13 Nov 2023.